Concerning measures to increase access to pharmacy services.
Summary
HB261336 expands access to pharmacy services in Colorado by requiring certain health benefit plans to cover pharmacist-provided health-care services when those services are within a pharmacist’s scope of practice. It also directs Medicaid to reimburse pharmacists for covered services that are within scope and not duplicative of other reimbursed pharmacy services. In addition, the bill prohibits health plans and carriers from discriminating against pharmacists solely because of the type of license or certification they hold, including in participation, referrals, reimbursement, indemnification, and network membership.
The bill also updates pharmacy practice law to create and define “final product verification,” a process in which a pharmacist may delegate certain final-check tasks to a certified pharmacy technician or intern under supervision. It requires pharmacies using such a program to maintain a continuous quality assessment system, create a program plan that preserves pharmacist time for direct patient care, and comply with Board of Pharmacy rules to be adopted by December 31, 2026. Finally, the bill expands pharmacists’ independent prescriptive authority to include certain non-controlled drugs, categories, and devices for children ages 5 through 11 under limited conditions, and clarifies related notification or referral requirements to a primary care provider.
Impact
The bill amends Colorado insurance, pharmacy practice, and Medicaid statutes. It changes section 10-16-144 to require coverage for pharmacist services within scope of practice and to bar licensure-based discrimination by health plans and carriers. It amends the pharmacy practice definitions in title 12 to add final product verification and broaden independent prescriptive authority for younger pediatric patients under specified limits. It also revises Medicaid reimbursement rules in section 25.5-5-511 so pharmacists may be reimbursed for medically necessary services within their scope of practice, subject to non-duplication requirements.
Sentiment
The available context suggests the bill was generally favorable and moved successfully through the legislature, ultimately being signed by the governor. The bill’s stated purpose is to increase access to pharmacy services, which indicates broad support for expanding pharmacist roles and patient access to care. No committee transcript or recorded vote data is provided, so there is no evidence in the supplied materials of organized opposition or divided sentiment.
Contention
The main policy tensions appear to be around expanding pharmacist authority and requiring insurer coverage. Health plans and carriers may view the nondiscrimination and coverage mandates as limiting network design, utilization management, or cost-control flexibility, although the bill expressly preserves some of that discretion. Another likely point of concern is patient safety and oversight in the new final product verification framework and the expanded authority to prescribe for younger children, which the bill addresses through supervision, quality-assessment, rulemaking, and referral/notification requirements. No specific stakeholder objections are included in the provided record.